Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication

被引:29
|
作者
Nolte-'t Hoen, Esther N. M.
Almeida, Catarina R.
Cohen, Nadia R.
Nedvetzki, Shlomo
Yarwood, Helen
Davis, Daniel M.
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England
[2] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1182/blood-2006-07-036509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The threat from cancer cells is inherently linked to cell-cycle progression, and viral genomes commonly replicate, for example, within episomes or proviruses, during mitosis. We report here that human natural killer (NK) cells bound cells In mitosis and attacked pathogenic cells In mitosis more effectively than the same cells in other stages of the cell cycle. Thus, cells in mitosis warrant and undergo heightened surveillance, a novel strategy for immunologic assessment of danger. Recognition of cells in mitosis involved ligation of activating NK-cell receptors and binding to target-cell hyaluronan, a component of the pericellular matrix known to be increased during mitosis. Direct interaction between activating NK-cell receptors and hyaluronan is possible, but other mechanisms consistent with our data are also discussed.
引用
收藏
页码:670 / 673
页数:4
相关论文
共 50 条
  • [1] Homing and function of human skin γδ T cells and NK cells:: Relevance for tumor surveillance
    Ebert, Lisa M.
    Meuter, Simone
    Moser, Bernhard
    JOURNAL OF IMMUNOLOGY, 2006, 176 (07): : 4331 - 4336
  • [2] Disarming a killer: novel viral infection of human NK Cells interferes with function and phenotype
    Campbell, T. M.
    McSharry, B. P.
    Steain, M.
    Ashhurst, T. M.
    Slobedman, B.
    Abendroth, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 305 - 305
  • [3] A novel strategy for preventing PERV transmission to human cells by remodeling the viral envelope glycoprotein
    Miyagawa, Shuji
    Nakatsu, Shino
    Hazama, Kenji
    Nakagawa, Takatoshi
    Kondo, Akihiro
    Matsunami, Katsuyoshi
    Yamamoto, Aki
    Yamada, Junko
    Miyazawa, Takayuki
    Shirakura, Ryota
    XENOTRANSPLANTATION, 2006, 13 (03) : 258 - 263
  • [4] A novel strategy for efficient cloning of human tumor-specific T cells
    Neelapu, Sattva S.
    Lee, S-T
    Wang, Y-H
    Sukhumalchandra, P.
    Molldrem, J.
    Wieder, E.
    Radvanyi, L.
    Hwu, P.
    Liu, Y-J
    Kwak, L.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S267 - S267
  • [5] HUMAN TUMOR-ASSOCIATED NK CELLS SECRETE INCREASED AMOUNTS OF INTERFERON-GAMMA AND INTERLEUKIN-4
    LORENZEN, J
    LEWIS, CE
    MCCRACKEN, D
    HORAK, E
    GREENALL, M
    MCGEE, JO
    BRITISH JOURNAL OF CANCER, 1991, 64 (03) : 457 - 462
  • [6] A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth
    Molina-Pena, Rodolfo
    Tudon-Martinez, Juan Carlos
    Aquines-Gutierrez, Osvaldo
    CANCERS, 2020, 12 (09) : 1 - 22
  • [7] Adaptive Memory of Human NK-like CD8+ T-Cells to Aging, and Viral and Tumor Antigens
    Luisa Pita-Lopez, Maria
    Pera, Alejandra
    Solana, Rafael
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [8] Identification of human tumor stem cells by a novel detection strategy based on comparative genomic FISH
    Little, S.
    Sandy, A.
    Ye, Y.
    Xiao, Y.
    Barsky, S. H.
    LABORATORY INVESTIGATION, 2008, 88 : 328A - 328A
  • [9] Identification of human tumor stem cells by a novel detection strategy based on comparative genomic FISH
    Little, S.
    Sandy, A.
    Ye, Y.
    Xiao, Y.
    Barsky, S. H.
    MODERN PATHOLOGY, 2008, 21 : 328A - 328A
  • [10] Targeting ITGA5 in pancreatic stellate cells as a novel strategy to restrain pancreatic tumor growth
    Kuninty, Praneeth
    de Geus, Sanne
    Bansal, Ruchi
    Schnittert, Jonas
    Kuppen, Peter
    Vahrmeijer, Alexander
    Ostman, Arne
    Sier, Cornelies
    Prakash, Jai
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)